Investigating IDA (BSG Guideline) - PowerPoint PPT Presentation

About This Presentation
Title:

Investigating IDA (BSG Guideline)

Description:

Title: Etiology of small-bowel bleeding Author: SYSTEM Last modified by: deb ghosh Created Date: 3/11/2005 6:00:54 PM Document presentation format – PowerPoint PPT presentation

Number of Views:171
Avg rating:3.0/5.0
Slides: 38
Provided by: Sys8134
Category:

less

Transcript and Presenter's Notes

Title: Investigating IDA (BSG Guideline)


1
  • Investigating IDA (BSG Guideline)
  • And
  • An overview of Obscure GI Bleed
  • Dr.D.Ghosh
  • Gastroenterology Registrar

2
  • Anaemia lt10-11.5g/dl for women
  • lt12.5-13.8g/dl for men
  • Not known at what level of Hb Ix should be
    initiated. No reason why mild anaemia should be
    less indicative of important disease than severe
    anaemia
  • Iron deficiency serum ferritinlt12
  • MCVlt 76
  • Transferrin satlt30
  • Bone marrow aspiration
  • Therapeutic response
  • Sr.transferrin receptor/ferritin ratio

3
Investigation
  • History - dietary,drugs and family hx
  • Examination-abd mass/cutaneous
  • GI evaluationall with confirmed IDA unless non
    GI blood loss
  • Order of Ix in absence of symptoms-local
    availability
  • OGD with small bowel bx yield 30-50
  • Barium meal with coeliac serology if unable
  • Colonoscopyunless OGD positive for Ca or coeliac
    ALL pts should have lower GI ix
  • Ba enema is a sufficent alternative with/without
    sigmoidoscopy (can omit in absence of lower GI
    symptoms and a normal PR Exam)
  • FOB is of no benefit in the investigation of IDA
    insensitive and nonspecific
  • The management of IDA is often suboptimal with
    most patients being incompletely investigated if
    at all

4
(No Transcript)
5
Iron treatment
  • Different formulations
  • Vit c
  • Parental iron
  • Target increase by 2 every 3wks
  • Replenish stores3 more months
  • Monitor3 monthly for a yr then after one yr
  • Reassuring to know that IDA does not return in
    most pts in whom no cause is found after ix

6
  • Co-morbidity appropriateness should be carefully
    considered and discussed with pts and carers.
  • Pre-menopausal women
  • 5-10 incidence in that group
  • Hx unreliable to quantify
  • Ix only ifgt45yrs
  • Ogd SI bx if upper GI symptoms
  • But coeliac serology in all
  • Lower GI ix only if symptoms,family hx,refractory
    after correction of potential cause
  • Post-gastrectomyif refractory or occuring long
    after

7
(No Transcript)
8
(No Transcript)
9
Etiology of small-bowel bleeding
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
Classification of vascular malformations that
cause gastrointestinal hemorrhage
14
Arteriovenous malformations in the
gastrointestinal tract
15
Endoscopic views of small-bowel arteriovenous
malformations
16
Endoscopic views of small-bowel arteriovenous
malformations
17
Small-bowel arteriovenous malformations as the
cause of gastrointestinal hemorrhage
18
Small-bowel tumors as the cause of
gastrointestinal hemorrhage
19
Gastrointestinal hemorrhage of obscure origin
arising from small-bowel tumors
20

21
Barium studies in the evaluation of small-bowel
bleeding
22
Types of nuclear medicine studies for the
evaluation of small-bowel bleeding
23
Diagnostic yield of nuclear medicine studies for
small-bowel bleeding
24
Diagnostic value of Meckel's scan in the adult
population
25
Arteriography in the diagnosis of small-bowel
bleeding
26
Arteriography in gastrointestinal bleeding
27
Enteroscopy in the diagnosis and management of
small-bowel hemorrhage
28
(No Transcript)
29
(No Transcript)
30
Yield of jejunoscopy for small-bowel bleeding
31
(No Transcript)
32
(No Transcript)
33
(No Transcript)
34
Treatment options for small-bowel bleeding
lesions
35
Evaluation and management of acute hemorrhage
36
Evaluation and management of chronic
gastrointestinal bleeding of obscure origin
37
  • Thank you
Write a Comment
User Comments (0)
About PowerShow.com